Kathryn Haskins
Concepts (403)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD4-Positive T-Lymphocytes | 36 | 2026 | 1129 | 5.500 |
Why?
| | Diabetes Mellitus, Type 1 | 83 | 2026 | 3890 | 5.270 |
Why?
| | Autoantigens | 35 | 2026 | 429 | 5.210 |
Why?
| | Mice, Inbred NOD | 73 | 2026 | 610 | 3.710 |
Why?
| | Islets of Langerhans | 48 | 2026 | 833 | 3.300 |
Why?
| | Chromogranin A | 9 | 2024 | 43 | 2.980 |
Why?
| | Insulin | 23 | 2026 | 2507 | 2.570 |
Why?
| | T-Lymphocytes | 54 | 2025 | 1982 | 2.530 |
Why?
| | Peptides | 19 | 2026 | 998 | 2.490 |
Why?
| | Receptors, Antigen, T-Cell | 28 | 2021 | 668 | 1.990 |
Why?
| | Epitopes, T-Lymphocyte | 11 | 2025 | 175 | 1.950 |
Why?
| | Islet Amyloid Polypeptide | 5 | 2018 | 48 | 1.850 |
Why?
| | Islets of Langerhans Transplantation | 7 | 2026 | 67 | 1.690 |
Why?
| | Diabetes Mellitus, Experimental | 15 | 2020 | 198 | 1.540 |
Why?
| | C-Peptide | 7 | 2026 | 189 | 1.530 |
Why?
| | Insulin-Secreting Cells | 10 | 2026 | 388 | 1.490 |
Why?
| | Autoimmunity | 15 | 2022 | 927 | 1.430 |
Why?
| | Peptide Fragments | 13 | 2026 | 699 | 1.410 |
Why?
| | Mice | 99 | 2026 | 18365 | 1.300 |
Why?
| | Immune Tolerance | 7 | 2026 | 379 | 1.270 |
Why?
| | T-Lymphocytes, Regulatory | 6 | 2026 | 389 | 1.170 |
Why?
| | Clone Cells | 30 | 2018 | 266 | 1.130 |
Why?
| | CD8-Positive T-Lymphocytes | 9 | 2026 | 917 | 1.110 |
Why?
| | Immunotherapy | 2 | 2026 | 657 | 1.090 |
Why?
| | Animals | 108 | 2026 | 38109 | 1.030 |
Why?
| | Epitopes | 13 | 2024 | 485 | 0.920 |
Why?
| | CD40 Antigens | 4 | 2012 | 90 | 0.830 |
Why?
| | Graft Survival | 2 | 2026 | 526 | 0.790 |
Why?
| | Antigen-Presenting Cells | 8 | 2014 | 160 | 0.790 |
Why?
| | T-Lymphocytes, Helper-Inducer | 3 | 2019 | 131 | 0.770 |
Why?
| | Adoptive Transfer | 16 | 2015 | 198 | 0.750 |
Why?
| | Lymphocyte Activation | 16 | 2020 | 1126 | 0.730 |
Why?
| | Mice, SCID | 15 | 2018 | 369 | 0.660 |
Why?
| | Th1 Cells | 5 | 2009 | 139 | 0.650 |
Why?
| | CD4 Antigens | 5 | 2013 | 139 | 0.570 |
Why?
| | Cells, Cultured | 13 | 2020 | 4155 | 0.560 |
Why?
| | Mice, Transgenic | 20 | 2021 | 2185 | 0.530 |
Why?
| | Mice, Inbred BALB C | 18 | 2016 | 1253 | 0.530 |
Why?
| | Nanoparticles | 3 | 2022 | 520 | 0.520 |
Why?
| | Pancreas | 6 | 2013 | 342 | 0.520 |
Why?
| | Recombinant Fusion Proteins | 3 | 2019 | 675 | 0.520 |
Why?
| | Recombination, Genetic | 1 | 2018 | 205 | 0.510 |
Why?
| | Histocompatibility Antigens Class II | 6 | 2013 | 364 | 0.480 |
Why?
| | Macrophages | 6 | 2009 | 1511 | 0.480 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 9 | 2012 | 331 | 0.430 |
Why?
| | CD40 Ligand | 2 | 2012 | 40 | 0.430 |
Why?
| | Autoimmune Diseases | 7 | 2018 | 463 | 0.410 |
Why?
| | Antigen Presentation | 3 | 2021 | 205 | 0.410 |
Why?
| | Prediabetic State | 3 | 2013 | 245 | 0.400 |
Why?
| | Th2 Cells | 2 | 2007 | 171 | 0.390 |
Why?
| | Histocompatibility Antigens | 3 | 2011 | 102 | 0.390 |
Why?
| | Spleen | 11 | 2013 | 508 | 0.360 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2007 | 1217 | 0.360 |
Why?
| | Mice, Knockout | 8 | 2021 | 3125 | 0.350 |
Why?
| | HLA-A2 Antigen | 2 | 2025 | 35 | 0.350 |
Why?
| | Oxidative Stress | 4 | 2007 | 1339 | 0.330 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 202 | 0.320 |
Why?
| | Flow Cytometry | 8 | 2015 | 1173 | 0.310 |
Why?
| | Specific Pathogen-Free Organisms | 3 | 2018 | 58 | 0.310 |
Why?
| | Macrophage Activation | 2 | 2007 | 193 | 0.300 |
Why?
| | Antigens, CD | 3 | 2008 | 555 | 0.300 |
Why?
| | Amino Acid Sequence | 8 | 2016 | 2157 | 0.290 |
Why?
| | Cytokines | 9 | 2009 | 2065 | 0.280 |
Why?
| | Diabetes Mellitus | 5 | 2014 | 1098 | 0.280 |
Why?
| | Mass Spectrometry | 4 | 2023 | 750 | 0.280 |
Why?
| | Interferon-gamma | 8 | 2020 | 784 | 0.280 |
Why?
| | Receptors, CCR8 | 1 | 2007 | 2 | 0.270 |
Why?
| | Chemokine CCL1 | 1 | 2007 | 2 | 0.270 |
Why?
| | Autoantibodies | 6 | 2025 | 1504 | 0.270 |
Why?
| | Cell Differentiation | 5 | 2026 | 2050 | 0.260 |
Why?
| | Major Histocompatibility Complex | 10 | 2006 | 229 | 0.260 |
Why?
| | HLA-DQ Antigens | 3 | 2021 | 173 | 0.260 |
Why?
| | Transforming Growth Factor beta | 1 | 2009 | 479 | 0.240 |
Why?
| | Humans | 42 | 2026 | 144957 | 0.240 |
Why?
| | Cell Line | 14 | 2013 | 2882 | 0.230 |
Why?
| | Disease Models, Animal | 4 | 2026 | 4569 | 0.230 |
Why?
| | Interleukin-10 | 2 | 2026 | 310 | 0.230 |
Why?
| | Female | 35 | 2026 | 78376 | 0.220 |
Why?
| | T-Lymphocyte Subsets | 4 | 2003 | 415 | 0.210 |
Why?
| | Thymus Gland | 5 | 2015 | 311 | 0.210 |
Why?
| | Tyrosine | 2 | 2005 | 222 | 0.210 |
Why?
| | Antibodies, Monoclonal | 12 | 2008 | 1524 | 0.190 |
Why?
| | Contrast Media | 1 | 2026 | 488 | 0.190 |
Why?
| | Drug Delivery Systems | 1 | 2026 | 381 | 0.190 |
Why?
| | Transglutaminases | 2 | 2013 | 159 | 0.180 |
Why?
| | Regeneration | 1 | 2004 | 197 | 0.180 |
Why?
| | Cell Movement | 4 | 2014 | 965 | 0.180 |
Why?
| | Metalloporphyrins | 1 | 2002 | 66 | 0.170 |
Why?
| | Antigens, Surface | 3 | 2000 | 157 | 0.170 |
Why?
| | CD11c Antigen | 2 | 2019 | 40 | 0.170 |
Why?
| | Polymorphism, Genetic | 1 | 2004 | 612 | 0.170 |
Why?
| | Molecular Sequence Data | 4 | 2016 | 2931 | 0.160 |
Why?
| | Crosses, Genetic | 3 | 2018 | 124 | 0.160 |
Why?
| | B-Lymphocytes | 3 | 2015 | 877 | 0.160 |
Why?
| | Transgenes | 1 | 2001 | 190 | 0.160 |
Why?
| | Gene Products, gag | 1 | 2020 | 38 | 0.160 |
Why?
| | Antigens, Differentiation | 1 | 2000 | 77 | 0.160 |
Why?
| | Glutamate Decarboxylase | 5 | 2008 | 165 | 0.150 |
Why?
| | Endogenous Retroviruses | 1 | 2020 | 38 | 0.150 |
Why?
| | HLA-DRB1 Chains | 1 | 2020 | 109 | 0.150 |
Why?
| | Cell Proliferation | 3 | 2019 | 2499 | 0.150 |
Why?
| | Mice, Inbred Strains | 9 | 1998 | 397 | 0.150 |
Why?
| | Insulinoma | 2 | 2002 | 28 | 0.150 |
Why?
| | Recurrence | 1 | 2022 | 1135 | 0.140 |
Why?
| | Animals, Genetically Modified | 1 | 2019 | 250 | 0.140 |
Why?
| | Immunoconjugates | 1 | 2000 | 137 | 0.140 |
Why?
| | Celiac Disease | 1 | 2021 | 308 | 0.140 |
Why?
| | Forkhead Transcription Factors | 1 | 2019 | 202 | 0.140 |
Why?
| | Cytoplasmic Granules | 3 | 2000 | 74 | 0.140 |
Why?
| | Exocytosis | 1 | 2018 | 84 | 0.140 |
Why?
| | Lymphoid Tissue | 1 | 2018 | 80 | 0.140 |
Why?
| | Immune System | 1 | 2019 | 179 | 0.130 |
Why?
| | Chromatography, Gel | 2 | 2012 | 131 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2012 | 2584 | 0.130 |
Why?
| | Leukocytes | 1 | 1998 | 295 | 0.130 |
Why?
| | Cell Division | 4 | 2004 | 766 | 0.120 |
Why?
| | Mice, Inbred C57BL | 6 | 2015 | 5997 | 0.120 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2002 | 223 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 851 | 0.120 |
Why?
| | Diabetic Angiopathies | 2 | 2011 | 263 | 0.120 |
Why?
| | Hybridomas | 11 | 2009 | 234 | 0.110 |
Why?
| | Male | 21 | 2025 | 72406 | 0.110 |
Why?
| | Antigens, Neoplasm | 2 | 1994 | 272 | 0.110 |
Why?
| | Biocompatible Materials | 2 | 2012 | 435 | 0.110 |
Why?
| | Microsatellite Repeats | 1 | 2015 | 157 | 0.110 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 2 | 2007 | 100 | 0.110 |
Why?
| | Cathepsin D | 2 | 2026 | 19 | 0.110 |
Why?
| | Serine Endopeptidases | 1 | 2015 | 128 | 0.110 |
Why?
| | Disease Progression | 3 | 2019 | 2852 | 0.110 |
Why?
| | CTLA-4 Antigen | 2 | 2008 | 104 | 0.110 |
Why?
| | Nitric Oxide | 3 | 2007 | 897 | 0.100 |
Why?
| | Histocompatibility Testing | 1 | 2013 | 121 | 0.100 |
Why?
| | Insulin, Regular, Human | 2 | 2024 | 47 | 0.100 |
Why?
| | Dendritic Cells | 2 | 2012 | 499 | 0.100 |
Why?
| | Microscopy, Fluorescence | 2 | 2012 | 418 | 0.100 |
Why?
| | Signal Transduction | 5 | 2012 | 5233 | 0.100 |
Why?
| | Primary Cell Culture | 1 | 2013 | 174 | 0.100 |
Why?
| | Citrulline | 1 | 2013 | 46 | 0.090 |
Why?
| | Amino Acid Motifs | 2 | 2010 | 224 | 0.090 |
Why?
| | Interleukin-2 | 4 | 2000 | 437 | 0.090 |
Why?
| | T-Cell Antigen Receptor Specificity | 3 | 2012 | 45 | 0.090 |
Why?
| | Fibrinogen | 1 | 2013 | 177 | 0.090 |
Why?
| | Proteomics | 2 | 2022 | 1195 | 0.090 |
Why?
| | Transduction, Genetic | 1 | 2012 | 133 | 0.090 |
Why?
| | Lymph Nodes | 2 | 2013 | 502 | 0.090 |
Why?
| | Arthritis, Experimental | 1 | 2013 | 141 | 0.080 |
Why?
| | Alleles | 2 | 2025 | 881 | 0.080 |
Why?
| | Antigens | 2 | 2024 | 347 | 0.080 |
Why?
| | Lymphocyte Transfusion | 3 | 2005 | 20 | 0.080 |
Why?
| | Complementarity Determining Regions | 2 | 2012 | 53 | 0.080 |
Why?
| | Immunodominant Epitopes | 2 | 2009 | 27 | 0.080 |
Why?
| | Child | 7 | 2025 | 22657 | 0.080 |
Why?
| | Transforming Growth Factor beta1 | 2 | 2012 | 178 | 0.080 |
Why?
| | Carotid Artery Diseases | 1 | 2011 | 69 | 0.080 |
Why?
| | HLA-A Antigens | 1 | 2010 | 52 | 0.080 |
Why?
| | Ovalbumin | 3 | 2021 | 190 | 0.080 |
Why?
| | Up-Regulation | 2 | 2013 | 852 | 0.080 |
Why?
| | Endothelium, Vascular | 2 | 2007 | 965 | 0.080 |
Why?
| | RNA, Messenger | 4 | 2005 | 2832 | 0.080 |
Why?
| | Receptors, Interleukin-2 | 2 | 2000 | 64 | 0.070 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 2006 | 27 | 0.070 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2009 | 57 | 0.070 |
Why?
| | Chromosome Mapping | 2 | 2004 | 510 | 0.070 |
Why?
| | CD28 Antigens | 1 | 2008 | 58 | 0.070 |
Why?
| | Adolescent | 5 | 2025 | 22453 | 0.070 |
Why?
| | Gene Expression | 1 | 2013 | 1490 | 0.070 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2008 | 54 | 0.070 |
Why?
| | Disease Susceptibility | 2 | 2004 | 348 | 0.070 |
Why?
| | Inducible T-Cell Co-Stimulator Protein | 1 | 2007 | 10 | 0.070 |
Why?
| | Polyethylene Glycols | 3 | 2012 | 655 | 0.070 |
Why?
| | Organ Specificity | 1 | 2008 | 313 | 0.070 |
Why?
| | Isoenzymes | 2 | 2006 | 299 | 0.070 |
Why?
| | CD11b Antigen | 1 | 2007 | 60 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2007 | 89 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2007 | 163 | 0.060 |
Why?
| | Chemotaxis | 1 | 2007 | 122 | 0.060 |
Why?
| | Biomarkers | 1 | 2018 | 4275 | 0.060 |
Why?
| | Hydrogels | 3 | 2012 | 700 | 0.060 |
Why?
| | Adult | 6 | 2025 | 40506 | 0.060 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2004 | 21 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 983 | 0.060 |
Why?
| | Mice, Mutant Strains | 3 | 1991 | 299 | 0.060 |
Why?
| | Microbubbles | 1 | 2026 | 53 | 0.060 |
Why?
| | Prostaglandins | 1 | 2005 | 94 | 0.060 |
Why?
| | Pancreatic Neoplasms | 1 | 1994 | 927 | 0.060 |
Why?
| | Enzyme-Linked Immunospot Assay | 1 | 2025 | 37 | 0.060 |
Why?
| | Genes, T-Cell Receptor | 1 | 2005 | 6 | 0.060 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 47 | 0.050 |
Why?
| | Receptors, Cytokine | 1 | 2005 | 36 | 0.050 |
Why?
| | Young Adult | 4 | 2025 | 14126 | 0.050 |
Why?
| | Species Specificity | 4 | 2006 | 574 | 0.050 |
Why?
| | Immunoglobulin Allotypes | 1 | 1984 | 9 | 0.050 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 2000 | 331 | 0.050 |
Why?
| | Cell Adhesion Molecules | 1 | 2005 | 178 | 0.050 |
Why?
| | Lymphocyte Depletion | 3 | 2000 | 132 | 0.050 |
Why?
| | Rats | 6 | 2000 | 5614 | 0.050 |
Why?
| | Mice, Congenic | 1 | 2004 | 23 | 0.050 |
Why?
| | Proinsulin | 1 | 2024 | 51 | 0.050 |
Why?
| | Chemokines | 1 | 2005 | 218 | 0.050 |
Why?
| | Molecular Mimicry | 1 | 2003 | 37 | 0.050 |
Why?
| | Arthritis, Rheumatoid | 1 | 2013 | 1169 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2005 | 758 | 0.050 |
Why?
| | Genes, RAG-1 | 1 | 2003 | 12 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2023 | 88 | 0.050 |
Why?
| | DNA Primers | 1 | 2004 | 512 | 0.050 |
Why?
| | Aging | 4 | 2005 | 1966 | 0.050 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 145 | 0.050 |
Why?
| | Immunoglobulin G | 2 | 1997 | 893 | 0.050 |
Why?
| | Extracellular Matrix | 1 | 2007 | 553 | 0.050 |
Why?
| | Solubility | 2 | 2000 | 242 | 0.050 |
Why?
| | Antibody Specificity | 5 | 1996 | 181 | 0.050 |
Why?
| | Respiratory Burst | 1 | 2002 | 18 | 0.050 |
Why?
| | Vasodilation | 1 | 2005 | 523 | 0.050 |
Why?
| | Ultrasonography | 1 | 2026 | 770 | 0.040 |
Why?
| | Molecular Weight | 5 | 2006 | 327 | 0.040 |
Why?
| | Glucose | 3 | 2007 | 1049 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2023 | 1048 | 0.040 |
Why?
| | Superoxide Dismutase | 1 | 2003 | 301 | 0.040 |
Why?
| | Cytoprotection | 1 | 2021 | 55 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2004 | 635 | 0.040 |
Why?
| | Cross Reactions | 2 | 2020 | 130 | 0.040 |
Why?
| | Leukemia L1210 | 1 | 2001 | 7 | 0.040 |
Why?
| | K562 Cells | 1 | 2021 | 93 | 0.040 |
Why?
| | L-Selectin | 1 | 2001 | 27 | 0.040 |
Why?
| | Phosphotyrosine | 1 | 2001 | 39 | 0.040 |
Why?
| | Interphase | 1 | 2001 | 38 | 0.040 |
Why?
| | Perforin | 1 | 2001 | 21 | 0.040 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2001 | 15 | 0.040 |
Why?
| | Antigens, Viral | 1 | 2021 | 182 | 0.040 |
Why?
| | Gene Rearrangement | 1 | 2002 | 155 | 0.040 |
Why?
| | fas Receptor | 1 | 2001 | 92 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2001 | 200 | 0.040 |
Why?
| | Integrins | 1 | 2001 | 90 | 0.040 |
Why?
| | Detergents | 1 | 2000 | 44 | 0.040 |
Why?
| | Chromatography, Ion Exchange | 1 | 2000 | 57 | 0.040 |
Why?
| | Heat-Shock Proteins | 2 | 2001 | 138 | 0.040 |
Why?
| | Hemocyanins | 1 | 2000 | 61 | 0.040 |
Why?
| | Abatacept | 1 | 2000 | 56 | 0.040 |
Why?
| | Mice, Inbred DBA | 3 | 2013 | 187 | 0.040 |
Why?
| | Cell Lineage | 1 | 2021 | 376 | 0.040 |
Why?
| | Glycoproteins | 1 | 2021 | 355 | 0.040 |
Why?
| | Maternal-Fetal Exchange | 2 | 1997 | 169 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2001 | 322 | 0.040 |
Why?
| | Rats, Inbred Strains | 3 | 1990 | 321 | 0.040 |
Why?
| | Clonal Anergy | 1 | 1999 | 54 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1258 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2609 | 0.040 |
Why?
| | Cell-Derived Microparticles | 1 | 2020 | 75 | 0.040 |
Why?
| | Viral Proteins | 1 | 2021 | 355 | 0.040 |
Why?
| | Macromolecular Substances | 3 | 1991 | 224 | 0.040 |
Why?
| | Pancreatitis | 1 | 2000 | 145 | 0.040 |
Why?
| | Transfection | 1 | 2001 | 940 | 0.040 |
Why?
| | Interleukin-13 | 1 | 1999 | 144 | 0.040 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2001 | 239 | 0.030 |
Why?
| | Intracellular Membranes | 1 | 1998 | 76 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2002 | 863 | 0.030 |
Why?
| | Muramidase | 1 | 1998 | 67 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2001 | 496 | 0.030 |
Why?
| | NF-kappa B | 1 | 2002 | 662 | 0.030 |
Why?
| | Immunity, Maternally-Acquired | 1 | 1997 | 19 | 0.030 |
Why?
| | Antibodies | 1 | 2000 | 403 | 0.030 |
Why?
| | Materials Testing | 2 | 2012 | 354 | 0.030 |
Why?
| | Multigene Family | 1 | 1997 | 204 | 0.030 |
Why?
| | Obesity | 1 | 1990 | 3082 | 0.030 |
Why?
| | Tumor Cells, Cultured | 2 | 2000 | 919 | 0.030 |
Why?
| | Cloning, Molecular | 3 | 2003 | 541 | 0.030 |
Why?
| | Cell Membrane | 1 | 2000 | 706 | 0.030 |
Why?
| | Animals, Newborn | 3 | 2005 | 902 | 0.030 |
Why?
| | Glutathione | 1 | 1998 | 375 | 0.030 |
Why?
| | Phosphorylation | 1 | 2001 | 1733 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 573 | 0.030 |
Why?
| | Insulin Antibodies | 1 | 1996 | 103 | 0.030 |
Why?
| | NADPH Oxidases | 2 | 2007 | 124 | 0.030 |
Why?
| | Immunization | 2 | 1996 | 374 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2000 | 1718 | 0.030 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1996 | 177 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1500 | 0.030 |
Why?
| | Thymocytes | 1 | 2015 | 34 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2001 | 2118 | 0.030 |
Why?
| | Stromal Cells | 1 | 2015 | 125 | 0.030 |
Why?
| | Mice, Inbred AKR | 4 | 1997 | 37 | 0.030 |
Why?
| | Genetic Linkage | 1 | 1995 | 273 | 0.030 |
Why?
| | Centrifugation, Density Gradient | 1 | 1994 | 40 | 0.030 |
Why?
| | Culture Techniques | 1 | 1994 | 67 | 0.030 |
Why?
| | Cell Fractionation | 1 | 1994 | 52 | 0.030 |
Why?
| | Journal Impact Factor | 1 | 2014 | 29 | 0.030 |
Why?
| | Binding Sites, Antibody | 2 | 1984 | 41 | 0.030 |
Why?
| | Genetic Markers | 1 | 1995 | 331 | 0.030 |
Why?
| | Antigen-Antibody Reactions | 2 | 1984 | 50 | 0.030 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 1993 | 16 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2000 | 1167 | 0.030 |
Why?
| | Rats, Inbred BB | 1 | 1993 | 5 | 0.020 |
Why?
| | Cell Survival | 2 | 2007 | 1098 | 0.020 |
Why?
| | Collagen Type II | 1 | 2013 | 54 | 0.020 |
Why?
| | CD8 Antigens | 1 | 1992 | 72 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 35928 | 0.020 |
Why?
| | Trinitrobenzenes | 1 | 1992 | 14 | 0.020 |
Why?
| | Adenoma, Islet Cell | 1 | 1992 | 6 | 0.020 |
Why?
| | Publishing | 1 | 2014 | 114 | 0.020 |
Why?
| | Hybrid Cells | 1 | 1992 | 49 | 0.020 |
Why?
| | Haptens | 1 | 1992 | 21 | 0.020 |
Why?
| | Immunosuppressive Agents | 2 | 2012 | 847 | 0.020 |
Why?
| | Immunity, Innate | 1 | 1998 | 846 | 0.020 |
Why?
| | Polymerase Chain Reaction | 2 | 1993 | 1054 | 0.020 |
Why?
| | Immunoglobulin Idiotypes | 4 | 1983 | 28 | 0.020 |
Why?
| | Kinetics | 1 | 1995 | 1629 | 0.020 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 1992 | 134 | 0.020 |
Why?
| | Periodicals as Topic | 1 | 2014 | 203 | 0.020 |
Why?
| | Base Sequence | 2 | 1993 | 2191 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2012 | 246 | 0.020 |
Why?
| | Neointima | 1 | 2011 | 18 | 0.020 |
Why?
| | Mice, Nude | 1 | 1993 | 688 | 0.020 |
Why?
| | Germ-Line Mutation | 1 | 2012 | 175 | 0.020 |
Why?
| | Mice, Inbred CBA | 1 | 1990 | 57 | 0.020 |
Why?
| | Colorado | 1 | 2001 | 4564 | 0.020 |
Why?
| | CD4 Lymphocyte Count | 1 | 2011 | 277 | 0.020 |
Why?
| | Collagen | 1 | 2013 | 456 | 0.020 |
Why?
| | Age Factors | 2 | 1995 | 3335 | 0.020 |
Why?
| | Genes, MHC Class II | 1 | 1989 | 76 | 0.020 |
Why?
| | Sex Factors | 1 | 1995 | 2114 | 0.020 |
Why?
| | Leukemia, Lymphoid | 2 | 2006 | 27 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2009 | 61 | 0.020 |
Why?
| | Pituitary Gland | 1 | 1989 | 148 | 0.020 |
Why?
| | Trypsin | 2 | 2006 | 76 | 0.020 |
Why?
| | Lymphokines | 1 | 1988 | 130 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2009 | 245 | 0.020 |
Why?
| | Cell Separation | 1 | 1988 | 307 | 0.020 |
Why?
| | Tissue Distribution | 2 | 1985 | 334 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2008 | 191 | 0.020 |
Why?
| | Salivary Glands | 1 | 2006 | 36 | 0.010 |
Why?
| | Kidney Transplantation | 1 | 1992 | 704 | 0.010 |
Why?
| | Mucoproteins | 1 | 2005 | 8 | 0.010 |
Why?
| | Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2005 | 3 | 0.010 |
Why?
| | Acetophenones | 1 | 2005 | 13 | 0.010 |
Why?
| | Onium Compounds | 1 | 2005 | 8 | 0.010 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 74 | 0.010 |
Why?
| | Hydrogen Peroxide | 1 | 2007 | 336 | 0.010 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2005 | 81 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2007 | 455 | 0.010 |
Why?
| | Drug Compounding | 1 | 2005 | 107 | 0.010 |
Why?
| | Acetylcholine | 1 | 2005 | 206 | 0.010 |
Why?
| | History, 20th Century | 1 | 2006 | 325 | 0.010 |
Why?
| | Precipitin Tests | 1 | 1984 | 93 | 0.010 |
Why?
| | Isoelectric Point | 1 | 1984 | 23 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 1993 | 2365 | 0.010 |
Why?
| | Immune Sera | 2 | 1997 | 77 | 0.010 |
Why?
| | Disulfides | 1 | 1984 | 96 | 0.010 |
Why?
| | Genes, T-Cell Receptor alpha | 1 | 2003 | 11 | 0.010 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 2003 | 23 | 0.010 |
Why?
| | Chemical Precipitation | 1 | 1983 | 39 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 277 | 0.010 |
Why?
| | Aorta | 1 | 2005 | 430 | 0.010 |
Why?
| | Protein Binding | 1 | 2009 | 2276 | 0.010 |
Why?
| | Receptors, Immunologic | 1 | 1983 | 206 | 0.010 |
Why?
| | Peptide Library | 1 | 2002 | 95 | 0.010 |
Why?
| | Haplotypes | 1 | 2003 | 490 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2005 | 1087 | 0.010 |
Why?
| | Inflammation | 2 | 2006 | 2880 | 0.010 |
Why?
| | Homeostasis | 1 | 2005 | 640 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2001 | 200 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 7183 | 0.010 |
Why?
| | Growth Inhibitors | 1 | 2000 | 39 | 0.010 |
Why?
| | Ligands | 1 | 2002 | 674 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 2000 | 117 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2000 | 162 | 0.010 |
Why?
| | Blood Glucose | 3 | 1999 | 2330 | 0.010 |
Why?
| | Pancreatic Ducts | 1 | 2000 | 81 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2000 | 235 | 0.010 |
Why?
| | Complement C5 | 1 | 1999 | 33 | 0.010 |
Why?
| | Cell Transplantation | 1 | 1999 | 39 | 0.010 |
Why?
| | H-2 Antigens | 1 | 1999 | 111 | 0.010 |
Why?
| | Epithelium | 1 | 2000 | 314 | 0.010 |
Why?
| | Models, Immunological | 1 | 1999 | 100 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2000 | 451 | 0.010 |
Why?
| | Interleukin-4 | 1 | 1999 | 206 | 0.010 |
Why?
| | Apoptosis | 1 | 2007 | 2430 | 0.010 |
Why?
| | Conalbumin | 1 | 1997 | 3 | 0.010 |
Why?
| | Superantigens | 1 | 1997 | 70 | 0.010 |
Why?
| | Enterotoxins | 1 | 1997 | 89 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 1999 | 315 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 1997 | 164 | 0.010 |
Why?
| | Genes, Immunoglobulin | 1 | 1996 | 29 | 0.010 |
Why?
| | Spodoptera | 1 | 1996 | 40 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2000 | 826 | 0.010 |
Why?
| | Baculoviridae | 1 | 1996 | 44 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 1999 | 524 | 0.010 |
Why?
| | Antibody Formation | 1 | 1996 | 294 | 0.010 |
Why?
| | Pregnancy | 2 | 1997 | 7191 | 0.010 |
Why?
| | Submandibular Gland | 1 | 1993 | 20 | 0.010 |
Why?
| | Staphylococcus aureus | 1 | 1997 | 460 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1993 | 141 | 0.010 |
Why?
| | Globins | 1 | 1989 | 21 | 0.000 |
Why?
| | Cricetulus | 1 | 1987 | 118 | 0.000 |
Why?
| | CD3 Complex | 1 | 1987 | 111 | 0.000 |
Why?
| | Cricetinae | 1 | 1987 | 304 | 0.000 |
Why?
| | Rabbits | 1 | 1987 | 648 | 0.000 |
Why?
| | Antigens, Ly | 1 | 1984 | 40 | 0.000 |
Why?
| | Isoelectric Focusing | 1 | 1983 | 30 | 0.000 |
Why?
| | Chickens | 1 | 1983 | 191 | 0.000 |
Why?
| | Immunologic Techniques | 1 | 1983 | 38 | 0.000 |
Why?
| | Birds | 1 | 1983 | 92 | 0.000 |
Why?
| | Molecular Conformation | 1 | 1983 | 148 | 0.000 |
Why?
| | DNA | 1 | 1989 | 1464 | 0.000 |
Why?
|
|
Haskins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|